The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with short- and long-term survival in metastatic HER2+ breast cancer.
 
Jose Pablo Leone
Consulting or Advisory Role - Minerva Biotechnologies
Research Funding - Kazia Therapeutics (Inst)
 
Julieta Leone
No Relationships to Disclose
 
Carlos Teodoro Vallejo
No Relationships to Disclose
 
Heather Anne Parsons
Research Funding - Puma Biotechnology (Inst)
 
Michael J. Hassett
Research Funding - IBM
 
Nancy U. Lin
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Affinia Therapeutics; Aleta Biotherapeutics; Artera; AstraZeneca; Daiichi Sankyo; Denali Therapeutics; Olema Pharmaceuticals; Pfizer; Prelude Therapeutics; Puma Biotechnology; Seagen; Voyager Therapeutics
Research Funding - Genentech (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett